VANCOUVER, Dec. 4, 2018 /CNW/ - 1933 Industries Inc. (the "Company" or "1933 Industries") (CSE: TGIF) (OTCQB: TGIFF) a licensed cultivator and producer of cannabis flower and concentrates and manufacturer of hemp/CBD products in Nevada, Colorado and California, is pleased to announce the appointment of Mr. Ryan Maarschalk as Chief Financial Officer, effective immediately. With a strong financial background, Mr. Maarschalk brings business valuation, mergers & acquisitions and public company experience.
Mr. Maarschalk is a Chartered Professional Accountant (CPA) and candidate for the Chartered Business Valuation (CBV) designation. As CFO of a large privately-held company in British Columbia, Mr. Maarschalk led the sale of that company to a publicly traded private equity firm, and ensured a smooth transition to public accounting standards and expectations. Prior to that, he was a successful entrepreneur and co-founder of a restaurant chain. In public practice, Mr. Maarschalk worked with a leading Canadian accounting firm and gained experience in the private and public sectors.
"Ryan's entrepreneurial background, coupled with his managerial experience overseeing all aspects of financial reporting and strategic goal setting will be an asset to the Company", said Mr. Joe Bleackley, COO of the Company. "As we evaluate accretive transactions in North America, Ryan's background in business valuations and M&A work will serve the Company well in executing our expansion plans."
Mr. Maarschalk grew up in Zimbabwe prior to obtaining an honours degree in Biomedical Science from Western Michigan University, where he also captained the NCAA tennis team. Prior to going into business and finance, Mr. Maarschalk played tennis professionally and coached the Junior Canadian national teams. Today, Mr. Maarschalk volunteers his time in tennis and serves on various boards.
The Company wishes to thank outgoing CFO Mr. Michael Hopkinson for his contributions to the Company.
About 1933 Industries Inc.
1933 Industries Inc. is a vertically integrated cannabis company with operations in the United States and Canada. Operating through three subsidiary companies, 1933 Industries owns licensed medical and adult-use cannabis cultivation and production assets, proprietary hemp-based, CBD infused products, CBD extraction services and a specialized cannabis advisory firm supporting clients in security, intelligence and due diligence. The Company owns 91% of both Alternative Medicine Association and Infused MFG and 100% of Spire Global Strategy.
Please visit our new website at www.1933industries.com
Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.
Notice regarding Forward Looking Statements: This news release contains forward-looking statements. The use of any of the words "anticipate", "continue", "estimate", "expect", "may", "will", "project", "should", "believe" and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this news release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company's disclosure documents, which can be found under the Company's profile on www.sedar.com. 1933 Industries undertakes no obligation to update publicly or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by law.
SOURCE 1933 Industries Inc.
For further information: Alexia Helgason, Corporate Communications Director, 604-674-4756 (ext. 1), [email protected]; Brayden Sutton, Director/President & CEO, 604-674-4756 (ext. 1)